Stereotactic fine-needle aspiration cytology of nonpalpable breast lesions

Abstract

sound-guided radiologic approaches. 11,12 In the current study, we present our prospective experience with stereotactic FNAC evaluation Received July 14, 1997; revision received October 14, 1997; accepted October 24, 1997. of mammographically detected, nonpalpable breast lesions.

The Evolving Role of Vacuum Assisted Biopsy of the Breast: A Progression from Fine‐Needle Aspiration Biopsy

“…References [14][15][16] and it is also not particularly suitable for microcalcifications. FNAC cannot distinguish between in situ and invasive diseases, thus hindering preoperative decision-making in regard to issues such as sentinel node biopsy [17,18], and hormone receptor status cannot be reliably assessed [19][20][21].…”

“…As result of these and other reports [9–11], the benefits of FNAB can be summarised as: It is a quick, easy and inexpensive technique to perform for palpable lesions in an outpatient setting taking less than 5 min. It is suitable for patients on anticoagulants, allowing effective haemostasis by direct pressure applied on the biopsy area. It is suitable for lesions close to adjacent structures such as skin, chest wall or implants. The strength of FNAB lies in its ability to diagnose or confirm probable benign disease (American College of Radiology BI‐RADS 3 [12]). However, FNAB/FNAC also has disadvantages, including a high non‐diagnostic rate of up to 40% [13]; high operator dependency for quality assurance with interpretation primarily relies on the competence of the cytopathologist. References [14–16] and it is also not particularly suitable for microcalcifications. FNAC cannot distinguish between in situ and invasive diseases, thus hindering pre‐operative decision‐making in regard to issues such as sentinel node biopsy [17, 18], and hormone receptor status cannot be reliably assessed [19–21].…”